Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shenggui Xu"'
Autor:
Xiankun Cao, Wenxin He, Kewei Rong, Shenggui Xu, Zhiqian Chen, Yuwei Liang, Shuai Han, Yifan Zhou, Xiao Yang, Hui Ma, An Qin, Jie Zhao
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Abstract Background Enhancer of zeste homolog 2 (EZH2) is a novel oncogene that can specifically trimethylate the histone H3 lysine 27 (H3K27me3) to transcriptionally inhibit the expression of downstream tumor-suppressing genes. As a small molecular
Externí odkaz:
https://doaj.org/article/7315dc1134a14d9da225444d4f46fa9e
Autor:
Shenggui Xu, Xiankun Cao, Zhenxing Yu, Wenxin He, Yichuan Pang, Wang Lin, Zhiqian Chen, Weizhong Guo, Xiongwei Lu, Chengshou Lin
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Osteolytic bone disorders are characterized by an overall reduction in bone mineral density which enhances bone ductility and vulnerability to fractures. This disorder is primarily associated with superabundant osteoclast formation and bone resorptio
Externí odkaz:
https://doaj.org/article/c8bf445519324e2885e0226ba5dd5fad
Autor:
Wang Lin, Shunyou Chen, Cuihua Yuan, Yingying Wang, Shenshen Zhang, Shenggui Xu, Guangsheng Li, Jiaqing Huang, weizhong guo, Chengshou Lin
Background The indirect reduction is one kind of micro-invasive technology. The most important mechanism of indirect reduction is traction.The purpose of this study was to independently develop a traction reduction device on lower limb fracture and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166a4451f661b787fca5b19c68df3e29
https://doi.org/10.21203/rs.3.rs-2155707/v1
https://doi.org/10.21203/rs.3.rs-2155707/v1
Publikováno v:
Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery. 27(11)
To construct recombinant lentiviral vectors of porcine bone morphogenetic protein 2 (BMP-2) gene and to detect BMP-2 gene activity and bone marrow mesenchymal stem cells (BMSCs) osteogenetic differentiation so as to lay a foundation of the further st
Autor:
Shenggui Xu, Wen-Ping Lin, Jianhua Lin, Yang Guoxin, Jie Huang, Fa-Sheng Wang, Yuan-Rong Cheng, Weinan Liu, Li Zhang, Wenbin Lan, Zhao-Yang Wu
Publikováno v:
Oncology research. 20(7)
The mTOR pathway is a central control of cell growth, proliferation, metabolism, and survival, and is deregulated in most cancers. Cancer cells are addicted to increased activity of mTOR kinase-mediated signaling pathways, leading to numerous inhibit